Paul Elkington

Paul Elkington

University of Southampton

H-index: 49

Europe-United Kingdom

About Paul Elkington

Paul Elkington, With an exceptional h-index of 49 and a recent h-index of 35 (since 2020), a distinguished researcher at University of Southampton, specializes in the field of Tuberculosis.

His recent articles reflect a diverse array of research interests and contributions to the field:

An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis

Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections

Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model

Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers

Three-dimensional culture modelling reveals divergent Mycobacterium tuberculosis virulence and antimicrobial treatment response

B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles

Elevated plasma matrix metalloproteinases associate with Mycobacterium tuberculosis blood stream infection and mortality in HIV-associated tuberculosis

Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding

Paul Elkington Information

University

Position

___

Citations(all)

6941

Citations(since 2020)

3423

Cited By

4937

hIndex(all)

49

hIndex(since 2020)

35

i10Index(all)

87

i10Index(since 2020)

76

Email

University Profile Page

Google Scholar

Paul Elkington Skills & Research Interests

Tuberculosis

Top articles of Paul Elkington

An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis

Proceedings of the National Academy of Sciences

2024/5/7

Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections

2022/1/6

Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model

Frontiers in Immunology

2024/4/30

Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers

JCI insight

2024/3/21

Three-dimensional culture modelling reveals divergent Mycobacterium tuberculosis virulence and antimicrobial treatment response

Cellular Microbiology

2024/3/11

B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles

2023/11/1

Mohamed Ahmed
Mohamed Ahmed

H-Index: 3

Paul Elkington
Paul Elkington

H-Index: 31

Elevated plasma matrix metalloproteinases associate with Mycobacterium tuberculosis blood stream infection and mortality in HIV-associated tuberculosis

medRxiv

2023

Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding

2022/12/1

Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10

Communications Biology

2022/12/1

The paradox of immune checkpoint inhibition re-activating tuberculosis

2022/11/1

Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study

Cancer Immunology, Immunotherapy

2022/11

Paul Elkington
Paul Elkington

H-Index: 31

Yuki Yamamoto
Yuki Yamamoto

H-Index: 3

Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis

Antibiotics

2022/9/20

Paul Elkington
Paul Elkington

H-Index: 31

Elevated plasma matrix metalloproteinase 8 associates with sputum culture positivity in pulmonary tuberculosis

The Journal of infectious diseases

2022/9/1

Respiratory protective equipment in the NHS: time to fund a cheap PAPR system

British Medical Journal

2022/7/15

Constantinos Regas
Constantinos Regas

H-Index: 1

Paul Elkington
Paul Elkington

H-Index: 31

Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

2022/3/1

Understanding the tuberculosis granuloma: the matrix revolutions

2022/2/1

Paul Elkington
Paul Elkington

H-Index: 31

Semi-quantitative detection of inflammatory biomarkers using a laser-patterned multiplexed lateral flow device

Talanta

2022/1/15

Paul Elkington
Paul Elkington

H-Index: 31

Animal models of ocular tuberculosis: implications for diagnosis and treatment

2021/11/17

Paul Elkington
Paul Elkington

H-Index: 31

T3 Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies sphingosine kinase 1 as a potential therapeutic target

2021/11/1

Powered respirators are effective, sustainable, and cost-effective personal protective equipment for SARS-CoV-2

Frontiers in Medical Technology

2021/10/14

See List of Professors in Paul Elkington University(University of Southampton)